Compare Oruka Therapeutics Inc. Common Stock (ORKA) vs Occidental Petroleum Corporation (OXY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Oruka Therapeutics Inc. Common Stock vs Occidental Petroleum Corporation — how do they compare? Oruka Therapeutics Inc. Common Stock trades at $75.2 (market cap $5.08B), while Occidental Petroleum Corporation trades at $61.77 (market cap $61.39B). The key difference: Occidental Petroleum Corporation is far larger — about 12.1× Oruka Therapeutics Inc. Common Stock's market cap, and Occidental Petroleum Corporation pays a 1.82% dividend while Oruka Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Oruka Therapeutics Inc. Common Stock for 0 Days and Occidental Petroleum Corporation for 92 Days on average.
| ORKA | OXY | |
|---|---|---|
Market Cap | $5.08B | $61.39B |
Volume | 685,276 | 8,708,264 |
Sector | Health | Energy |
52-Week High | $113.08 | $66.24 |
52-Week Low | $26.19 | $38.92 |
Typical Hold Time | 0 Days | 92 Days |
Enterprise Value | $4.21B | $80.15B |
Dividend Yield | — | 1.82% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Occidental Petroleum (OXY) trades at $61.65, up 0.85% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $70.92. The company has consistently beaten earnings estimates in recent quarters, with Q3 2026 results expected soon. Financials show strong profitability with a 30.32% net income margin and robust cash flow, though revenue has declined from 2022 peaks. Recent news highlights focus on dividend reliability and Goldman Sachs' upgrade citing cash flow targets and debt reduction.
OXY presents a favorable outlook with earnings momentum, attractive valuation multiples, and analyst support, but faces risks from oil price volatility and competitive pressures. The stock's upside potential hinges on execution of debt reduction and sustained operational efficiency amid energy market fluctuations.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.
Read more on ORKA →About Occidental Petroleum Corporation
Occidental Petroleum is an independent exploration and production company with operations in the United States, Latin America, and the Middle East. At the end of 2021, the company reported net proved reserves of 3.5 billion barrels of oil equivalent. Net production averaged 1,174 thousand barrels of oil equivalent per day in 2021 at a ratio of 75% oil and natural gas liquids and 25% natural gas.
Read more on OXY →
